Samar Alsafadi
Impact in
- Ophthalmology top 5%
- Ocular Oncology and Treatments
-
- Cancer-related molecular mechanisms research
Papers in
-
- RNA Research and Splicing 4
- RNA and protein synthesis mechanisms 4
- RNA modifications and cancer 4
- Genomics and Chromatin Dynamics 2
-
- Ocular Oncology and Treatments 9
- Co-authors
- Sergio Roman‐Roman (12 shared papers)Marc‐Henri Stern (9 shared papers)Alexandre Houy (6 shared papers)Tatiana Popova (4 shared papers)Michel Wassef (3 shared papers)Sophie Piperno‐Neumann (5 shared papers)Martin Dutertre (2 shared papers)Aude Battistella (1 shared paper)
- Journals
- Cancers (4 papers)European Journal of Cancer (2 papers)Cancer Research (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Scientific Reports (1 paper)
- Partner nations
- FranceNetherlandsUnited States
In The Last Decade
Samar Alsafadi
24 papers receiving 666 citations
Peers
Comparison fields: 5 of 68
- Ophthalmology 115
- Cancer Research 126
- Molecular Biology 525
- Hematology 66
- Oncology 151
Countries citing papers authored by Samar Alsafadi
This map shows the geographic impact of Samar Alsafadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar Alsafadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar Alsafadi more than expected).
Fields of papers citing papers by Samar Alsafadi
This network shows the impact of papers produced by Samar Alsafadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar Alsafadi. The network helps show where Samar Alsafadi may publish in the future.
Co-authors
The 25 scholars most cited alongside Samar Alsafadi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 270 | |
| 2 | 2013 | 75 | |
| 3 | 2014 | 46 | |
| 4 | 2020 | 38 | |
| 5 | 2018 | 35 | |
| 6 | 2019 | 34 | |
| 7 | 2009 | 25 | |
| 8 | 2020 | 20 | |
| 9 | 2020 | 20 | |
| 10 | 2013 | 16 | |
| 11 | 2021 | 13 | |
| 12 | 2008 | 12 | |
| 13 | 2019 | 10 | |
| 14 | 2022 | 9 | |
| 15 | 2023 | 9 | |
| 16 | 2023 | 8 | |
| 17 | 2022 | 8 | |
| 18 | 2016 | 7 | |
| 19 | 2015 | 5 | |
| 20 | 2011 | 4 |
About Samar Alsafadi
Samar Alsafadi is a scholar working on Molecular Biology, Ophthalmology, Oncology, Cell Biology and Cancer Research, having authored 24 papers that have together received 672 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (9 papers), Hippo pathway signaling and YAP/TAZ (5 papers), Cancer-related Molecular Pathways (5 papers), RNA Research and Splicing (4 papers), Cancer Genomics and Diagnostics (4 papers), RNA and protein synthesis mechanisms (4 papers), RNA modifications and cancer (4 papers) and Genomics and Chromatin Dynamics (2 papers). The work is most often cited by research in Ophthalmology (115 citations), Cancer Research (126 citations), Molecular Biology (525 citations), Hematology (66 citations) and Oncology (151 citations). Samar Alsafadi has collaborated with scholars based in France, Netherlands and United States. Frequent co-authors include Sergio Roman‐Roman, Marc‐Henri Stern, Alexandre Houy, Tatiana Popova, Michel Wassef, Sophie Piperno‐Neumann, Martin Dutertre, Aude Battistella, Émilie Henry and Franck Tirode. Their work appears in journals such as Cancers, European Journal of Cancer, Cancer Research, JNCI Journal of the National Cancer Institute and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.